Healthcare -
Biotechnology - NASDAQ - US
$ 8.83
-2.75 %
$ 517 M
Market Cap
-3.18
P/E
CGEM - TOTAL CURRENT ASSETS
Total Current Assets CGEM - Cullinan Oncology, Inc.
480 M
LAST VALUE
27.25%
2 YEAR CAGR
69.60%
5 YEAR CAGR
0.00%
10 YEAR CAGR